Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DDI Study of Telmisartan/S-Amlodipine and Rosuvastatin in Healthy Volunteers
NCT02047175Phase 1Completed
- Sponsor
- Chong Kun Dang Holdings
- Start
- Feb 2014
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of telmisartan + levamlodipine in hypertension (HTN) and hyperlipidemia (2 arms), sponsored by Chong Kun Dang Holdings. Primary endpoints: Area Under the Concentration-time Curve at Steady State and Maximum Plasma Concentration at Steady State. Started Feb 2014; status: completed.
02
Drugs
telmisartan + levamlodipine
03
Conditions
hypertension (HTN)hyperlipidemia
Beyond the preview
Go deeper on NCT02047175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02047175.